Kaitlyn Arsenault
2023
In 2023, Kaitlyn Arsenault earned a total compensation of $1.3M as Chief Financial Officer at Skye Bioscience, a 171% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $136,000 |
---|---|
Option Awards | $138,056 |
Salary | $340,000 |
Stock Awards | $656,234 |
Total | $1,270,290 |
Arsenault received $656.2K in stock awards, accounting for 52% of the total pay in 2023.
Arsenault also received $136K in non-equity incentive plan, $138.1K in option awards and $340K in salary.
Rankings
In 2023, Kaitlyn Arsenault's compensation ranked 957th out of 3,006 executives tracked by ExecPay. In other words, Arsenault earned more than 68.2% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 957 out of 3,006 | 68th |
Division Manufacturing | 567 out of 1,650 | 66th |
Major group Chemicals And Allied Products | 388 out of 918 | 58th |
Industry group Drugs | 377 out of 881 | 57th |
Industry Pharmaceutical Preparations | 254 out of 637 | 60th |
Source: SEC filing on September 23, 2024.
Arsenault's colleagues
We found one more compensation record of an executive who worked with Kaitlyn Arsenault at Skye Bioscience in 2023.
2023
Punit Dhillon
Skye Bioscience